{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:06:27Z","timestamp":1764936387695},"reference-count":26,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2005,8,23]],"date-time":"2005-08-23T00:00:00Z","timestamp":1124755200000},"content-version":"vor","delay-in-days":1756,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Cancer Research"],"published-print":{"date-parts":[[2000,11]]},"abstract":"<jats:p>Histone deacetylases are promising targets for cancer treatment. Here we studied the <jats:italic>in vitro<\/jats:italic> effects of a potent histone deacetylase inhibitor, FK228 (formerly FR901228), on human leukemia\/lymphoma cells and cell lines compared with normal hematopoietic cells. In a lymphoma cell line, Raji, a nanomolar concentration of FK228 induced G1 arrest and\/or apoptotic cell death, depending on the concentration and exposure time. Growth of lymphoid cell lines including Raji (<jats:italic>N<\/jats:italic>=13) was inhibited by 50% (IC<jats:sub>50<\/jats:sub>) after 2\u2010day treatment at concentrations of 0.83 to 1.87 ng\/ml. Viability of clinical samples from patients with acute lymphoblastic leukemia was decreased by 50% at 0.78\u00b10.46 ng\/ml, whereas the IC<jats:sub>50<\/jats:sub> values for normal mononuclear cells from peripheral blood and bone marrow were 2.3\u00b10.96 and 7.8\u00b11.0 ng\/ml, respectively. The IC<jats:sub>50<\/jats:sub> values for normal progenitor cells were 3.1, 4.4 and 7.8 ng\/ml for BFU\u2010E, CFU\u2010GM and CFU\u2010Mix, respectively. Expression levels of HDAC\u20101 and HDAC\u20103 proteins, which varied among cell lines, but were stable during the treatment with FK228, did not correlate with the sensitivity to FK288. This novel agent might be useful in the treatment of lymphoid malignancies, because the above concentrations are clinically achievable <jats:italic>in vivo<\/jats:italic> according to a recent clinical study.<\/jats:p>","DOI":"10.1111\/j.1349-7006.2000.tb00899.x","type":"journal-article","created":{"date-parts":[[2005,8,23]],"date-time":"2005-08-23T08:51:03Z","timestamp":1124787063000},"page":"1154-1160","source":"Crossref","is-referenced-by-count":33,"title":["Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells"],"prefix":"10.1111","volume":"91","author":[{"given":"Makoto","family":"Murata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Towatari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kosugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsune","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuzo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehiko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Naoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,23]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5260.371"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/47412"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-9525(98)01438-3"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.5.2075"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)44885-X"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"22429","DOI":"10.1016\/S0021-9258(18)41547-5","article-title":"Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase","volume":"268","author":"Kijima M.","year":"1993","journal-title":"J. Biol. Chem."},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/43710"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1994.1248"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.7786"},{"key":"e_1_2_1_11_2","first-page":"3697","article-title":"Induction of caspase\u20103 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial\/cytochrome c\u2010dependent pathway","volume":"57","author":"Medina V.","year":"1997","journal-title":"Cancer Res."},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0298-126"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.21.1621"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401508"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01933.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.13.14.1991"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.47.301"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1998.4027"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.47.315"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1182\/blood.V94.4.1401","article-title":"Depsipeptide (FR901228): a novel therapeutic agent with selective,. in vitro activity against human B\u2010cell chronic lymphocytic leukemia cells","volume":"94","author":"Byrd J. C.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_1_21_2","unstructured":")Marshall J. L. Dahut W. L. Rizvi N. Wainer L. W. Chassaing C. Figuierra M.andHawkins M. J.Phase I trial and pharmacokinetics analysis of depsipeptide in patients with advanced cancer.Proc. 35th Annu. Meet. ASCO(1998)."},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80708-4"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80521-8"},{"key":"e_1_2_1_24_2","first-page":"4266","article-title":"Sp3, but not Sp1, mediates the transcriptional activation of the p21\/WAF1\/Cip1 gene promoter by histone deacetylase inhibitor","volume":"59","author":"Sowa Y.","year":"1999","journal-title":"Cancer Res."},{"key":"e_1_2_1_25_2","first-page":"4392","article-title":"Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95\/CD95 ligand expression in human neuroblastoma","volume":"59","author":"Glick R. D.","year":"1999","journal-title":"Cancer Res."},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5340.1059"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90141-K"}],"container-title":["Japanese Journal of Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2000.tb00899.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2000.tb00899.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T18:07:29Z","timestamp":1698602849000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2000.tb00899.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2000,11]]}},"alternative-id":["10.1111\/j.1349-7006.2000.tb00899.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2000.tb00899.x","archive":["Portico"],"relation":{},"ISSN":["0910-5050"],"issn-type":[{"value":"0910-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}